METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer.

Wu, Jui-Chuang; Wu, Guang-Jer

Wu, Jui-Chuang; Wu, Guang-Jer.

Afiliación

Wu JC; Department of Chemical Engineering, Chung Yuan Christian University, Taoyuan City 32023, Taiwan.
Wu GJ; Research Center for Circular Economy, Chung Yuan Christian University, Taoyuan City 32023, Taiwan.

Biomedicines ; 11(1)2023 Jan 13.

Article en En | MEDLINE | ID: mdl-36672713

Palabras clave

METCAM; Western blot and ELISA; biomarker of prostate cancer; biotinylated antibodies; magnetic beads-enriched array display; magnetic beads-purified serum; nano-gold conjugated antibodies; streptavidin; therapeutic target for prostate cancer; traditional and modified LFIA; tumorigenesis and metastasis driver

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google